TJP1 and inflammatory bowel disease: For example, loss of SEPT9 may impair the junctional recruitment of key TJ components, including ZO-1, ZO-2, occludin, claudins, and JAM-A, which are often mislocalized in the intestinal mucosa of patients with IBD and in DSS-challenged mouse models (56).